Head-to-head · WeighScore
10rx vs Invigor Medical
By GLP-1 ScorecardUpdated
Score comparison
Invigor Medical has the higher recorded score — 86.1/100 to 66.1/100.
Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | 10rx | Invigor Medical |
|---|---|---|
| WeighScore | 66.1/100 | 86.1/100 |
| Grade | C | B |
| Site position | #222 | #10 |
| Semaglutide | $99/mo equivalent, billed $297 quarterly (advertised compounded injection base; confirm pharmacy choice and renewal) | $199/mo |
| Tirzepatide | $149/mo equivalent, billed $447 quarterly (advertised compounded injection base; confirm pharmacy choice and renewal) | $339/mo |
| Coverage | All-state coverage claimed in company blog; confirm prescribed product, clinician and dispensing eligibility for your state | Not disclosed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #222 · C
Strengths
- Publishes quarterly base charges and monthly equivalents for semaglutide and tirzepatide
- Advertises the same medication-specific package price across available strengths
- Advertises consultations, shipping and ongoing support without separate service fees
- Terms identify 10Rx, Inc.; the directory names Wasef Health Physicians and three pharmacy brands
What to consider
- Quarterly pricing is an upfront commitment; exact renewal charge and usable supply remain unverified
- A separate campaign lists a $75 Hallandale charge; applicability and frequency need confirmation
- Fixed-term plans require completion; canceling future renewals does not establish a refund for unused treatment
- Initial cancellation must precede prescribing; refill requests require 48 hours before pharmacy transmission, not necessarily before billing
- Named networks do not establish the treating practice, assigned dispensing branch or individual state eligibility
Site position #10 · B
Strengths
- Mid-market pricing on both molecules
- Long-running operator
What to consider
- No explicit states list
- Compounded only
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.